Literature DB >> 9163657

White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children.

M Korppi1, T Heiskanen-Kosma, M Leinonen.   

Abstract

We evaluated the applicability of C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), white blood cell count (WBC), and absolute neutrophil count (ANC), in the screening of pneumococcal (PNC) pneumonia in children. In 1981-1982, 161 children were treated for radiologically verified community-acquired pneumonia in the hospital during a period of 12 months. The Streptococcus pneumoniae aetiology of infection was studied by antigen, antibody and immune complex assays in acute and convalescent sera. In acute blood samples, CRP was measured by the immunonephelometric method, ESR by the Westergren method, WBC using an automatic cell counter, and thereafter the ANC was calculated after microscopic examination of peripheral smears. CRP and ESR were significantly higher in patients with alveolar (n=53) than in those with interstitial (n=108) pneumonia. CRP, ESR and ANC were significantly higher in PNC (n=29) than in viral (n=23) pneumonia. The values in mixed PNC and viral infections (n=17) were approximately midway between PNC and viral cases. All cases with serologic evidence of S. pneumoniae aetiology were combined (n=46) for calculation of diagnostic parameters. When a cut-off limit of 60 mg x L(-1) was used, CRP had a sensitivity of 26% and a specificity of 83% in the screening of PNC pneumonia. We conclude that C-reactive protein and erythrocyte sedimentation rate have a limited capacity to differentiate between pneumococcal and nonpneumococcal pneumonia. C-reactive protein is recommended as the first-line method of screening, and the value of 60 mg x L(-1) as the cut-off limit.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9163657     DOI: 10.1183/09031936.97.10051125

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  33 in total

1.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  BTS guidelines for the management of pleural infection in children.

Authors:  I M Balfour-Lynn; E Abrahamson; G Cohen; J Hartley; S King; D Parikh; D Spencer; A H Thomson; D Urquhart
Journal:  Thorax       Date:  2005-02       Impact factor: 9.139

Review 3.  Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

Authors:  Victor van der Meer; Arie Knuistingh Neven; Peterhans J van den Broek; Willem J J Assendelft
Journal:  BMJ       Date:  2005-06-24

4.  Persistent systemic inflammation and atypical enterocolitis in patients with NEMO syndrome.

Authors:  Laurence E Cheng; Bittoo Kanwar; Haig Tcheurekdjian; James P Grenert; Mica Muskat; Melvin B Heyman; Joseph M McCune; Diane W Wara
Journal:  Clin Immunol       Date:  2009-04-16       Impact factor: 3.969

5.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

6.  Diagnostic Testing and Hospital Outcomes of Children with Neurologic Impairment and Bacterial Pneumonia.

Authors:  Joanna Thomson; Matt Hall; Jay G Berry; Bryan Stone; Lilliam Ambroggio; Rajendu Srivastava; Samir S Shah
Journal:  J Pediatr       Date:  2016-08-22       Impact factor: 4.406

Review 7.  Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.

Authors:  Matti Korppi
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Santiago Ewig; Jana Papassotiriou; Jan Kunde; Reinhard Marre; Heike von Baum; Norbert Suttor; Tobias Welte
Journal:  Respir Res       Date:  2009-07-12

9.  Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases.

Authors:  Veronica Marcos; Phillip Latzin; Andreas Hector; Sebastian Sonanini; Florian Hoffmann; Martin Lacher; Barbara Koller; Philip Bufler; Thomas Nicolai; Dominik Hartl; Matthias Griese
Journal:  Respir Res       Date:  2010-03-19

10.  Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion.

Authors:  Yang-Ching Ko; Wen-Pin Wu; Chi-Sen Hsu; Mong-Ping Dai; Chien-Chih Ou; Chih-Hsiung Kao
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.